Study: Most Of Early-Stage Cancer Research Wrong

Two thought provoking and disturbing studies out Wednesday raise major questions about conduct of the “War on Cancer.” One examines the quality of basic research and the other concludes that half of current cancer deaths could be prevented.

Almost 90 percent of early stage cancer research looking for improved treatments is wrong, according to scientists at biotechnology giant Amgen and the MD Anderson Cancer Center. The researchers describe their findings as “shocking.”

More